<DOC>
	<DOC>NCT02683980</DOC>
	<brief_summary>Twenty (20) subjects presenting with a hyperplasia enlarged prostate and candidates for surgery will undergo a single treatment for ablation of the prostate using the study device.Follow up visits are scheduled for the day of release from the hospital and at 1 and 3 months post procedure. The primary objective of this study is to explore Vaporization efficacy and safety when treating PBH (Benign prostatic hyperplasia ) with the contact side firing fiber with recommended settings.</brief_summary>
	<brief_title>Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Subject will be older than 18 years of age Subject was diagnosed with enlarged prostate of ≥ 30 gr volume Subject is a candidate for surgery treatment Subject is willing and has signed the Informed Consent Form AUA score ≥ 12 Qmax &lt;15 mL/s Need to perform concomitant procedure, other than prostate vaporization PVR &gt; 300mL Current Urine retention and Pdet &lt;40 cm H20 Documented or suspected prostate cancer and / or bladder cancer Neurogenic bladder disorder / neurogenic voiding dysfunction Urethral strictures Previous prostatic, bladder neck, or urethral surgery Known history of spinal cord injury Urogenital trauma Bladder neck stricture Evidence of urinary tract infection History of chronic prostatitis</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>